The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

Biocon aims to grow through new product launches in generics and biosimilars, bolstered by the Viatris acquisition. This ...

BENGALURU: Biocon Foundation has unveiled a breathtaking public art spectacle, turning over 50 Metro pillars between Huskur ...

Biocon Foundation transforms metro pillars into art celebrating Bengaluru's unsung heroes, merging heritage with urban landscape.

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

The University of Glasgow has launched an innovative and exciting new postgraduate study programme with Indian biopharmaceutical giant Biocon.

Biocon is set for major growth in the next 2-3 years, propelled by new generics and biosimilars. The Viatris acquisition ...

Nandita Vijayasimha, Bengaluru Friday, February 14, 2025, 08:00 Hrs [IST] ...

Investors need to recognize Karnataka as destination where investments grow & innovation thrives: Kiran Mazumdar-Shaw: Nandita Vijayasimha, Bengaluru Thursday, February 13, 2025, ...

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like ...